EP2900831
Magnákvörðun efnasambanda frá fjölsykruleifum á ekki-afoxandi enda
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
26.9.2013EP published:
21.11.2018EP application number:
13840682.2
EP translation filed:
19.12.2018Grant published:
15.1.2019EPO information:
European Patent Register
Max expiry date:
25.9.2033Expiry date:
25.9.2026Next due date:
30.9.2026
Title:
QUANTIFICATION OF NON-REDUCING END GLYCAN RESIDUAL COMPOUNDS
Timeline
Today
26.9.2013EP application
21.11.2018EP Publication
19.12.2018Translation submitted
15.1.2019Registration published
25.9.2026Expires
Owner
Name:
BioMarin Pharmaceutical Inc.Address:
105 Digital Drive, 94949, Novato, CA, US
Inventor
Name:
CRAWFORD, Brett, E.Address:
Poway, CA, US
Name:
BROWN, Jillian, R.Address:
Poway, CA, US
Name:
GLASS, Charles, A.Address:
San Diego, CA, US
Name:
BEITEL, Jim, R.Address:
San Diego, CA, US
Name:
JACKMAN, Robin, M.Address:
San Diego, CA, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201213629321Date:
27.9.2012Country:
US
Classification
Categories:
G01N 33/68
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 1.9.2019
Expires: 25.9.2020
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 1.9.2020
Expires: 25.9.2021
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 31.8.2021
Expires: 25.9.2022
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 19.8.2022
Expires: 25.9.2023
Payer: Patice ehf.
Number: 11
Paid: 15.9.2023
Expires: 25.9.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 22.8.2024
Expires: 25.9.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 16.9.2025
Expires: 25.9.2026
Payer: Árnason Faktor ehf.